mounjaro
Entity, reached from Hormuz.
- Evidence
- 61 documents · 34 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 3 Sept 2026, last seen 9 Oct 2026
- Measured
- 28% of mentions say something specific about it; the rest only name it
- As of
- 9 Oct 2026
Where this comes from
- 24/7 Wall St. · 2026-10-07 · Lilly’s Worst Entry Points Were Its Most Hyped Approvals Mounjaro and Zepbound (opens the source in a new tab)
- Medical Daily · 2026-09-29 · FDA Flagged GLP-1 Vision Loss Signal in 2025, but U.S. Ozempic and Mounjaro Labels Still Lack NAION Warning (opens the source in a new tab)
- Latest Science News -- ScienceDaily · 2026-09-27 · Zepbound and Mounjaro may turn on the body’s calorie-burning brown fat (opens the source in a new tab)
- Korea Times · 2026-09-22 · Wegovy, Mounjaro help Korean doctor navigate lifelong struggle with obesity (opens the source in a new tab)
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with glp-1 (56 documents)seen together
- co-mentioned with eli lilly (39 documents)seen together
- co-mentioned with zepbound (33 documents)seen together
- co-mentioned with fda (20 documents)seen together
- co-mentioned with novo nordisk (19 documents)seen together
- co-mentioned with glp-1s (14 documents)seen together
- co-mentioned with studie (14 documents)seen together
- co-mentioned with buy (13 documents)seen together
- co-mentioned with foundayo (12 documents)seen together
- co-mentioned with nyse (12 documents)seen together